Equity Profile

EW

Edwards Lifesciences Corporation

Health CareHealth Care Equipment$52.9B

Jul23Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Edwards Lifesciences Corporation focuses on heart valve technologies and critical care monitoring. As a leader in the health care equipment sector, its innovations are crucial for improving patient outcomes in cardiovascular care.

Key Metrics to Watch

EPS Growth

Earnings per share growth is a key indicator of profitability and operational efficiency, which investors closely monitor.

N/A

Revenue Performance

Revenue figures provide insight into the company's sales growth and market demand for its products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

EW Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+87.79%

Avg Stock Reaction

-0.42%

Last Quarter Recap

In Q1-2026, Edwards reported an EPS of $0.78, exceeding expectations by 7.59%. However, the stock fell 2.22% the following day, indicating mixed market reactions despite the earnings beat.

Management Promises & Guidance

Continued focus on innovation in heart valve technology.
Commitment to expanding market presence in critical care monitoring.
Plans to enhance operational efficiency to improve margins.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Edwards' upcoming earnings, given its strong track record of beating EPS estimates. However, the lack of specific guidance may lead to uncertainty.

Bull Case

If Edwards continues its trend of beating EPS estimates, it could signal strong operational performance and increased investor confidence.

Bear Case

Conversely, any signs of slowing revenue growth or market share loss could raise concerns about the company's competitive position.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth in the heart valve segment?

This metric will be critical in assessing the company's ability to maintain its market leadership and drive future growth.

How is Edwards addressing competition in the critical care monitoring space?

Understanding the competitive landscape will help investors gauge potential risks to market share and profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Edwards to capture additional market share in the heart valve segment, driven by recent innovations.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

Recent trends in cardiovascular health demand may not be fully reflected in current estimates.

Key Risk

If revenue growth in the heart valve segment exceeds 10%, it could significantly alter market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate revolves around Edwards' ability to sustain its growth trajectory amidst increasing competition.

Bull Confirmed If

Revenue growth of 10% or more in the heart valve segment would confirm the bull case.

Bear Confirmed If

Any decline in market share or revenue growth below 5% would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.93%

Historical Avg

±0.7%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±5.9% while EW has averaged ±0.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

32.1%

Calls (397K)P/C Ratio: 0.49Puts (340K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Edwards beats expectations, history suggests the stock could rise around 0.74% on the first day, reinforcing confidence in its growth strategy.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, with the stock likely remaining stable as investors digest the details.

Miss

Should the company miss expectations, history suggests a potential decline of about 0.33%, raising concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the heart valve segment.
2Insights into market share changes in critical care monitoring.
3Management's outlook on competitive pressures.
4Details on operational efficiency improvements.
5Comments on overall market demand trends in cardiovascular health.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Calix, Inc.

Company Snapshot

Key Metrics to Watch

EPS Growth

Earnings per share growth is a key indicator of profitability and operational efficiency, which investors closely monitor.

N/A

Revenue Performance

Revenue figures provide insight into the company's sales growth and market demand for its products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

EW Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+87.79%

Avg Stock Reaction

-0.42%

Last Quarter Recap

In Q1-2026, Edwards reported an EPS of $0.78, exceeding expectations by 7.59%. However, the stock fell 2.22% the following day, indicating mixed market reactions despite the earnings beat.

Management Promises & Guidance

Continued focus on innovation in heart valve technology.
Commitment to expanding market presence in critical care monitoring.
Plans to enhance operational efficiency to improve margins.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Edwards' upcoming earnings, given its strong track record of beating EPS estimates. However, the lack of specific guidance may lead to uncertainty.

Bull Case

If Edwards continues its trend of beating EPS estimates, it could signal strong operational performance and increased investor confidence.

Bear Case

Conversely, any signs of slowing revenue growth or market share loss could raise concerns about the company's competitive position.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth in the heart valve segment?

This metric will be critical in assessing the company's ability to maintain its market leadership and drive future growth.

How is Edwards addressing competition in the critical care monitoring space?

Understanding the competitive landscape will help investors gauge potential risks to market share and profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Edwards to capture additional market share in the heart valve segment, driven by recent innovations.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

Recent trends in cardiovascular health demand may not be fully reflected in current estimates.

Key Risk

If revenue growth in the heart valve segment exceeds 10%, it could significantly alter market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate revolves around Edwards' ability to sustain its growth trajectory amidst increasing competition.

Bull Confirmed If

Revenue growth of 10% or more in the heart valve segment would confirm the bull case.

Bear Confirmed If

Any decline in market share or revenue growth below 5% would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.93%

Historical Avg

±0.7%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±5.9% while EW has averaged ±0.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

32.1%

Calls (397K)P/C Ratio: 0.49Puts (340K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Edwards beats expectations, history suggests the stock could rise around 0.74% on the first day, reinforcing confidence in its growth strategy.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, with the stock likely remaining stable as investors digest the details.

Miss

Should the company miss expectations, history suggests a potential decline of about 0.33%, raising concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the heart valve segment.
2Insights into market share changes in critical care monitoring.
3Management's outlook on competitive pressures.
4Details on operational efficiency improvements.
5Comments on overall market demand trends in cardiovascular health.